Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: Preliminary results

Paolo Anderlini, Rima M. Saliba, Celina Ledesma, Christina Chancoco, Amin M. Alousi, Elizabeth J. Shpall, Uday R. Popat, Chitra M. Hosing, Issa F. Khouri, Yago Nieto, Stefan Ciurea, Anas Younes, Michelle A. Fanale, Sandra Acholonu, Rosamar Valverde, Richard E. Champlin

Research output: Contribution to journal › Letter › peer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: Preliminary results'. Together they form a unique fingerprint.